Medical Research

GeoVax Reveals Promising Multi-Antigen COVID-19 Vaccine with Strong Immunocompromised Patient Response
GeoVax's experimental COVID-19 vaccine GEO-CM04S1 demonstrates exceptional immune responses across diverse populations, particularly in immunocompromised patients, potentially offering a more robust alternative to existing vaccines.

Soligenix's HyBryte™ Demonstrates Promising Results in Rare Skin Cancer Treatment
A novel skin cancer therapy shows a 75% response rate in treating cutaneous T-cell lymphoma, offering potential hope for patients with limited treatment options. The treatment's safety profile and rapid results could significantly impact rare cancer care.

Zelenirstat Shows Promise in Disrupting Triple-Negative Breast Cancer Cell Growth
Pacylex Pharmaceuticals' lead drug zelenirstat demonstrates potential to disrupt mitochondrial function in triple-negative breast cancer cells, potentially offering new insights into cancer treatment strategies.

Kairos Pharma Secures Department of Defense Grant for Lung Cancer Biomarker Research
Kairos Pharma has received a Department of Defense grant to advance research on lung cancer biomarkers, furthering its innovative approach to targeting drug resistance in cancer treatments. The company is progressing clinical trials for its lead candidates ENV105 and KROS101 with promising potential in oncology.

Ohio State Researchers Uncover Potential Breakthrough in Glioblastoma Treatment
Scientists have identified a key enzyme, PGM3, that could be crucial in developing more effective treatments for glioblastoma, one of the deadliest forms of brain cancer by targeting a critical growth pathway.

American Heart Association Awards $15 Million to Study Women's Cardiovascular-Kidney-Metabolic Health
The American Heart Association is funding groundbreaking research to understand how unique risk factors impact women's cardiovascular and kidney diseases. Three research centers will investigate critical aspects of cardiovascular-kidney-metabolic syndrome across different life stages.

Portuguese Researchers Uncover Promising Immunotherapy Approach for Colorectal Cancer
A breakthrough discovery by Portuguese researchers reveals a new type of white blood cell with exceptional tumor identification capabilities, potentially revolutionizing colorectal cancer treatment through targeted immunotherapy.

Childhood Trauma Linked to Higher Risk of Immune Disorders, Study Reveals
A recent study published in Heliyon demonstrates a significant correlation between childhood maltreatment and increased risk of immune-related disorders like psoriasis and rheumatoid arthritis, with women showing higher susceptibility.

Dr. Nupur Ghoshal Receives Alois Alzheimer Award for Groundbreaking Dementia Research
Dr. Nupur Ghoshal, a distinguished neurologist and researcher at Washington University School of Medicine, has been honored with the prestigious Alois Alzheimer Award for her significant contributions to understanding and advancing Alzheimer's and dementia research.

Utah's Life Sciences Showcase at State Capitol Highlights $22B Industry Growth
Utah's burgeoning life sciences sector, representing $22 billion in GDP and employing 180,000 residents, will demonstrate its economic impact and healthcare innovations to state legislators at the annual Life Sciences Day on the Hill event.

Neutra Corp Expands into Clinical Research with New Site Management Program
Healthcare company Neutra Corp launches a technology-driven Site Management Organization pilot program to improve clinical trial efficiency and patient outcomes, marking a significant shift in how clinical research sites are managed and supported.

American Heart Association Launches $3M Initiative to Transform Advanced Heart Failure Care
With heart failure affecting 6.7 million American adults and expected to reach 8 million by 2030, the American Heart Association has launched a major initiative to improve access to advanced treatment options and specialist care, particularly for underserved populations.

Common Migraine Drug Shows Promise in Reducing Stroke Risk for Women
New research reveals propranolol, a widely-used medication for migraines and high blood pressure, may significantly reduce ischemic stroke risk in women with migraines, particularly those without aura, highlighting an important advancement in women's cardiovascular health management.

Study Reveals Higher Mental Health Risks for Child Stroke Survivors
New research indicates children who survive strokes face significantly higher rates of anxiety, depression, and physical symptoms compared to their peers, with age 9 identified as a critical period for emotional challenges. This finding highlights the need for enhanced mental health screening and support in pediatric stroke care.

Mediterranean Diet Linked to Enhanced Brain Health in Hispanic Adults, Study Shows
A new study reveals significant brain health benefits for Hispanic/Latino adults following a Mediterranean diet, with improvements in brain connectivity and structure independent of cardiovascular factors, highlighting important implications for the fastest-growing ethnic group in the U.S.

Breakthrough Blood Test Could Revolutionize Early Stroke Treatment
A new blood test measuring brain protein levels shows promise in quickly distinguishing between bleeding and clot-based strokes before patients reach the hospital, potentially transforming emergency stroke care and improving patient outcomes.

Common Oral Bacteria Linked to Higher Stroke Mortality, Study Finds
New research reveals that Streptococcus anginosus, a common mouth and gut bacteria, is associated with increased stroke risk and worse outcomes in stroke survivors, potentially revolutionizing how we assess and prevent stroke risk through oral health management.

Study Shows Simpler Stroke Warning Signs More Memorable for Public
Research reveals F.A.S.T. stroke acronym is more effective for public memory recall than BE-FAST, though both successfully encourage emergency response, highlighting the importance of simplified public health messaging in stroke awareness.

Regular Dental Flossing Linked to Significant Reduction in Stroke and Heart Rhythm Risks
A major study reveals that regular dental flossing may reduce stroke risk by up to 44% and lower the risk of atrial fibrillation, offering an accessible and affordable way to improve cardiovascular health.

Major Healthcare Partnership Aims to Revolutionize Oral Thrush Treatment
A new three-way partnership between Shear Kershman Labs, Texas A&M College of Dentistry, and Innovative MedTech Inc. promises to transform oral healthcare through an innovative drug delivery system that could benefit millions of patients suffering from oral thrush.